Nutrishus Brands, Inc. – 612938 – 07/28/2021

Information on using aspirin daily, over-the-counter, with other medicines, as well as its side effects

July 18, 2025: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement

This discussion will show how USP public standards strengthen quality, streamline development, support regulatory compliance, and overall, increase regulatory predictability for drugs.

FOR IMMEDIATE RELEASE – December 10, 2025 – Albuquerque, New Mexico, MediNatura New Mexico, Inc. is voluntarily recalling one lot of ReBoost Nasal Spray to the consumer level. The product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, a

The Food and Drug Administration is holding a public, two-day workshop entitled Development of Drugs for the Treatment of Congenital Cytomegalovirus (CMV) Infection and Neonatal Enterovirus Infection.

Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaboration